Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc. In tandem, Sanara agreed to make a minority investment in cash for equity in BMI. Developed by Biomimetic Innovations Ltd, OsStic®, is a disruptive new bio-adhesive bone void filler technology which was granted a Breakthrough Device Designation by the U.S. Food and Drug Administration on December 10, 2023.

The orthopedic elite celebrated a banner year in fiscal 2023; no company in the top 10 list reported revenue loss. The reason cited by most was the long-heralded return of elective surgery pacing, after the pandemic caused a dearth in those procedures.

Smith+Nephew has formed a global Advisory Board—within the framework of its new Orthopaedics for All initiative—to boost diversity in the industry. The board will strive to build equity, break biases, and inspire inclusion for individuals wishing to pursue careers in orthopedic surgery. There is a significant disparity of women in orthopedic surgery compared to men. According to multiple studies, only 15% of all orthopedic residents were women and just 7.4% were practicing orthopedic surgeons in the United States during 2022. Several factors may contribute to this inequity including greater vulnerability to work-family conflict, less supportive references than their male counterparts, and less national research funding compared to men. Smith+Nephew aims to address these long-standing challenges headfirst and help set new standards in patient-centric care.